« U.S. probes Roche, Glaxo diet drug over liver injury (Reuters)
Meat, Dairy Won’t Up Odds for Breast Cancer (HealthDay) »

FDA Investigating Weight-Loss Drug Over Reports of Liver Damage (HealthDay)

HealthDay - TUESDAY, Aug. 25 (HealthDay News) — As U.S. health officials
announced Monday that they are investigating the weight-loss drug orlistat
for possible incidents of liver damage, experts noted the drug might not
even work well enough to warrant such potential risks.

This entry was posted on Friday, August 28th, 2009 at 6:30 am and is filed under Google. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.